- IIROC Trade Resumption - BETR
- BetterLife Pharma Secures Lock-Up Agreements From Shareholders of Altum
- IIROC Trading Halt - BETR
- BetterLife Pharma Announces Appointment of Dr. Eleanor Fish, a leading expert on interferon activity against Covid-19, to its Advisory Board
- BetterLife Pharma announces release of exploratory study on treatment of Covid-19 patients in Wuhan with Interferon
- BetterLife Pharma announces Interferon Alpha-2b Covid-19 news regarding its emergence as a potential treatment for COVID-19
- BetterLife Pharma Confirms Re-Pricing of Warrants
- BetterLife Pharma Highlights Results from Recent Clinical Reports and Studies on use of Interferon and Announces Appointment of Dr. Mark Swaim and Engagement of IR Group
- BetterLife Pharma Enters into a Licensing Agreement
- BetterLife Pharma Provides Shareholder Update
BetterLife Pharma Inc (NPAT:FRA) closed at 0.126, 350.00% above the 52 week low of 0.028 set on Mar 20, 2020.
0.028Mar 20 20200.33Jul 01 2019
Markit short selling activity
|Market cap||34.42m CAD|
Data delayed at least 15 minutes, as of May 28 2020 07:10 BST.